tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MRSN Stock Latest News

Mersana Therapeutics Approves Key Proposals at Annual Meeting
Company AnnouncementsMersana Therapeutics Approves Key Proposals at Annual Meeting
14d ago
8K
MRSN
Promising Developments in Mersana Therapeutics’ Emi-Le Program Bolster Positive Outlook for TNBC Treatment
PremiumRatings
Promising Developments in Mersana Therapeutics’ Emi-Le Program Bolster Positive Outlook for TNBC Treatment
23d ago
MRSN
Mersana Therapeutics Reports Positive Phase 1 Trial Results
PremiumCompany Announcements
Mersana Therapeutics Reports Positive Phase 1 Trial Results
26d ago
8K
MRSN
Mersana Therapeutics reports additional interim Phase 1 data for Emi-Le
PremiumThe Fly
Mersana Therapeutics reports additional interim Phase 1 data for Emi-Le
26d ago
MRSN
Promising Clinical Trial Data and Upcoming Presentations Bolster Buy Rating for Mersana Therapeutics
PremiumRatings
Promising Clinical Trial Data and Upcoming Presentations Bolster Buy Rating for Mersana Therapeutics
1M ago
MRSN
Promising Efficacy and Strategic Positioning of Mersana Therapeutics’ Emi-Le Drive Buy Rating
PremiumRatingsPromising Efficacy and Strategic Positioning of Mersana Therapeutics’ Emi-Le Drive Buy Rating
1M ago
MRSN
Mersana Therapeutics price target raised to $10 from $9 at Truist
Premium
The Fly
Mersana Therapeutics price target raised to $10 from $9 at Truist
1M ago
MRSN
Mersana Therapeutics Reports Promising Clinical Advances
Premium
Company Announcements
Mersana Therapeutics Reports Promising Clinical Advances
1M ago
MRSN
Mersana Therapeutics’ Earnings Call: Mixed Outlook with Clinical Gains
PremiumCompany Announcements
Mersana Therapeutics’ Earnings Call: Mixed Outlook with Clinical Gains
1M ago
MRSN
Positive Developments in Mersana Therapeutics’ TNBC Trials and Stable Financial Position Support Buy Rating
PremiumRatings
Positive Developments in Mersana Therapeutics’ TNBC Trials and Stable Financial Position Support Buy Rating
1M ago
MRSN
Promising Clinical Trial Results and Strategic Development Drive Buy Rating for Mersana Therapeutics
PremiumRatings
Promising Clinical Trial Results and Strategic Development Drive Buy Rating for Mersana Therapeutics
1M ago
MRSN
Mersana Therapeutics reports Q1 EPS (19c), consensus (19c)
PremiumThe Fly
Mersana Therapeutics reports Q1 EPS (19c), consensus (19c)
1M ago
MRSN
Mersana Therapeutics (MRSN) Q1 Earnings Cheat Sheet
PremiumPre-EarningsMersana Therapeutics (MRSN) Q1 Earnings Cheat Sheet
2M ago
MRSN
Strategic Restructuring and Focus on Emi-Le Drive Buy Rating for Mersana Therapeutics
Premium
Ratings
Strategic Restructuring and Focus on Emi-Le Drive Buy Rating for Mersana Therapeutics
2M ago
MRSN
Mersana Therapeutics Announces Strategic Restructuring Plan
Premium
Company Announcements
Mersana Therapeutics Announces Strategic Restructuring Plan
2M ago
8K
MRSN
Mersana Therapeutics implements restructuring plan, will reduce workforce by 55%
PremiumThe Fly
Mersana Therapeutics implements restructuring plan, will reduce workforce by 55%
2M ago
MRSN
Positive Outlook for Mersana Therapeutics Amid Strategic Developments and Financial Stability
PremiumRatings
Positive Outlook for Mersana Therapeutics Amid Strategic Developments and Financial Stability
4M ago
MRSN
Positive Outlook for Mersana Therapeutics: Buy Rating Backed by Promising Pipeline and Strong Financial Position
PremiumRatings
Positive Outlook for Mersana Therapeutics: Buy Rating Backed by Promising Pipeline and Strong Financial Position
4M ago
MRSN
Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges
PremiumCompany Announcements
Mersana Therapeutics’ Viability in Question Amidst Persistent Financial Losses and Funding Challenges
4M ago
MRSN
Mersana Therapeutics Reports Progress and Financial Results
PremiumCompany AnnouncementsMersana Therapeutics Reports Progress and Financial Results
4M ago
MRSN
Mersana Therapeutics’ Earnings Call Highlights Clinical Progress and Financial Gains
Premium
Company Announcements
Mersana Therapeutics’ Earnings Call Highlights Clinical Progress and Financial Gains
4M ago
MRSN
Mersana Therapeutics: Strong Buy Rating Backed by Robust Financial Performance and Strategic Market Positioning
Premium
Ratings
Mersana Therapeutics: Strong Buy Rating Backed by Robust Financial Performance and Strategic Market Positioning
4M ago
MRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >